Patients who underwent a gastric bypass and develop an irondeficiency postoperatively. The medical condition which is investigated is irondeficiency
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients who underwent a gastric bypass and developped an irondeficiency postoperatively (ferritin=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: iron deficiency preoperatve, bloodtransfusions during study period, ironcontaining nutritional supplements except the 'standard' multivitamins after bariatric surgery, decreased renal failure, excessive manstruational blood loss, anemia not caused by iron deficiency, accumulation of iron, hypersensitivity for one of the medicinal products, psychiatric illness, pregnancy. Acute and chronic infection or other inflammationreactions, liver dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: evaluation on teh optimal treatment for an irondificiency after a roux- en -y gastric bypass;Secondary Objective: What is the effective time of Ferinject? Evaluate the patients preference for either oral treatment or intravenous treatment;Primary end point(s): normal value serum ferritin;Timepoint(s) of evaluation of this end point: 6,12,26 and 53 weeks after starting therapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): enquetes with the preferece for oral or intravenous ironsuppletion;Timepoint(s) of evaluation of this end point: 6,12,26 and 53 weeks after starting therapy | — |
Countries
Netherlands
Contacts
Rijnstate